
J Neuropsychiatry Clin Neurosci 17:496-502, November 2005
doi: 10.1176/appi.neuropsych.17.4.496
© 2005 American Neuropsychiatric Association
Depression and Stages of Huntingtons Disease
Jane S. Paulsen, Ph.D.,
Carissa Nehl, B.S.,
Karin Ferneyhough Hoth, M.A.,
Jason E. Kanz, M.S.,
Michelle Benjamin, B.S.,
Rachel Conybeare, B.S.,
Bradley McDowell, Ph.D. and
Beth Turner, B.S.The Huntington Study Group
Received March 9, 2004; revised May 25, 2004; accepted June 18, 2004. From the University of Iowa School of Medicine, Department of Psychiatry, Iowa City, Iowa. Address correspondence to Dr. Paulsen, Ph.D., University of Iowa, 1-305 Medical Education Building, Iowa City, IA 52242; jane-paulsen{at}uiowa.edu (E-mail).
Individuals with manifest Huntingtons disease (HD) were interviewed with regard to the presence, frequency, and severity of depression symptoms to better characterize depressed mood across the disease course in HD. Rates of depression were more than twice that found in the general population. One-half reported that they had sought treatment for depression, and more than 10% reported having at least one suicide attempt. The proportion of HD patients endorsing significant depression diminished with disease progression. Despite the public health impact of depression, available treatments are underutilized in HD, and research is needed to document the efficacy and effectiveness of standard depression treatments in this population.
This article has been cited by other articles:

|
 |

|
 |
 
E. van Duijn, E.M. Kingma, and R.C. van der Mast
Psychopathology in Verified Huntington's Disease Gene Carriers
J Neuropsychiatry Clin Neurosci,
November 1, 2007;
19(4):
441 - 448.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2005
American Neuropsychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|